Northwest Biotherapeutics Inc

Pharmaceutical company · Bethesda, Maryland, United States · OTC: NWBO

Northwest Biotherapeutics Inc is a pharmaceutical company headquartered in Bethesda, Maryland, United States. Its shares trade on OTC under the ticker NWBO. It has reported private securities offerings to the US SEC, most recently $880,000 sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Northwest Biotherapeutics at a glance

Typepharmaceutical company

HeadquartersBethesda, Maryland, United States

Stock listingOTC: NWBO

SEC industryPharmaceutical Preparations

SEC CIK1072379

What does Northwest Biotherapeutics do?

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $880,000 sold (2018).

Frequently asked questions about Northwest Biotherapeutics

Where is Northwest Biotherapeutics headquartered?

Northwest Biotherapeutics Inc is headquartered in Bethesda, Maryland, United States.

What does Northwest Biotherapeutics do?

Northwest Biotherapeutics Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Northwest Biotherapeutics a public company?

Yes. Northwest Biotherapeutics Inc trades on OTC under the ticker NWBO.

Similar companies

Gain Therapeutics, Inc.Bethesda, Maryland, United States
Pocket Naloxone Corp.Bethesda, Maryland, United States
CNBX Pharmaceuticals Inc.Bethesda, Maryland, United States
United BioSource CorpBethesda, Maryland, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Cartesian Therapeutics, Inc.Frederick, Maryland, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences